famotidine has been researched along with Exanthem in 2 studies
Famotidine: A competitive histamine H2-receptor antagonist. Its main pharmacodynamic effect is the inhibition of gastric secretion.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Salehi, M | 1 |
| Khalili, H | 1 |
| Jahani, Z | 1 |
| Rasoolinejad, M | 1 |
| Ghiasvanad, F | 1 |
| Scheinfeld, N | 1 |
| Wesson, K | 1 |
| Perry, P | 1 |
| Weinberg, J | 1 |
2 other studies available for famotidine and Exanthem
| Article | Year |
|---|---|
Famotidine's Possible Cutaneous Rash in COVID-19 Patients: An Adverse Effect Case Series.
Topics: COVID-19 Drug Treatment; Exanthema; Famotidine; Female; Humans; Male; Middle Aged; SARS-CoV-2; Skin | 2022 |
Acute generalized exanthematous pustulosis resembling toxic epidermal necrolysis caused by famotidine.
Topics: Diagnosis, Differential; Drug Eruptions; Exanthema; Famotidine; Female; Histamine H2 Antagonists; Hu | 2003 |